At BioCanRx, we are incredibly proud of our HQP and their dedication to cancer immunotherapy research. Whether they are working on viruses in the lab or examining the socioeconomic barriers to adopting certain treatments in Canada, each one plays a unique role in strengthening our network and expertise in immunotherapy. BioCanRx is invested in… Read more »
Category: News
Both Sides of the Learning Institute Experience at the 2023 Summit for Cancer Immunotherapy
BioCanRx Learning Institute Patient/Caregiver Perspective By Randy Thompson, Patient Scholar/Advocate When the notice for patient/caregiver applications to the 2023 BioCanRx Immunotherapy Summit popped up in my Inbox, I was immediately intrigued because it was happening in my hometown of Ottawa, ON. Then I realized I knew nothing about cancer immunotherapy and trashed… Read more »
BioCanRx Welcomes Strategic Science Fund Investment
Ottawa, ON, December 6, 2023 – Today, the Honourable François-Philippe Champagne, Canada’s Minister of Innovation, Science and Industry, and the Honourable Mark Holland, Minister of Health, announced support for 24 third-party science and research organizations – including BioCanRx – under the new Strategic Science Fund (SSF). “On behalf of our network of… Read more »
2023 Summit4CI: The HQP Experience
By Zaid Taha (Ottawa Hospital Research Institute) and Hyojin Song (University of Calgary), HQP Working Group members Another successful Summit for Cancer Immunotherapy (Summit4CI) was taken in Ottawa, Ontario (so-called “la Capitale du Canada”) this year! The 4-day summit was filled with intriguing and insightful talks given by great speakers from diverse fields along… Read more »
Successful 2023 Summit for Cancer Immunotherapy
BioCanRx’s seventh scientific conference is now on the books! Ottawa, Ontario, was the setting for the 2023 Summit for Cancer Immunotherapy (Summit4CI) held from October 1-4. Network members, scientists, clinicians, trainees and economists along with representatives from industry, patient groups, charities and government gathered in the nation’s capital to explore the latest progress in… Read more »
BioCanRx Summer Students Tell All
This past summer, 16 undergraduate students from across Canada were chosen to take part in a BioCanRx-funded research internship in cancer immunotherapeutics. We are very proud of the knowledge and growth our summer students have gained and we wish them all the best in their future studies. Curious to know what these students were… Read more »
What are your Research Priorities for AYA Cancer in Canada?
The Adolescent and Young Adult (AYA) Cancer Priority Setting Partnership (PSP) is bringing together patients, caregivers, and clinicians to establish the top 10 research priorities for AYA cancer in Canada. The first national survey for the priority setting partnership is now live! In this survey, we are collecting responses from the AYA cancer… Read more »
IDEA IMPACT STORIES: BIOCANRX
IDEA Impact Stories : BioCanRX
2023 Imagine Lecture Award Recipient
Congratulations to the 2023 Imagine Lecture Award Recipient! BioCanRx is pleased to announce the recipient of the 2023 Imagine Lecture Award. Congratulations to Emma Gerber, PhD Candidate, The Ottawa Hospital Research Institute! Inspired by our patient and caregiver community who ask “what if there is another way” for patient care, the goal of… Read more »
Where Are They Now: Taha Azad
At BioCanRx, we are incredibly proud of our HQP and their dedication to cancer immunotherapy research. Whether they are working on viruses in the lab or examining the socioeconomic barriers to adopting certain treatments in Canada, each one plays a unique role in strengthening our network and expertise in immunotherapy. BioCanRx is invested in… Read more »
